SCHEMBL19979028

SCHEMBL19979028

COc1ccc(COC[C@@H]2CC(C)C(=O)O2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.40
LMNA P02545 1/20 0.40
GRM2 Q14416 2/20 0.40
GLA P06280 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
IDO1 P14902 2/20 0.38
AGXT P21549 2/20 0.38
TRPV6 Q9H1D0 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
MEN1 O00255 1/20 0.36
CASP3 P42574 1/20 0.36
KMT2A Q03164 1/20 0.36
SENP8 Q96LD8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22569916 0.85 LMNA (0.56) CYP3A4TSHRLMNAMAPT
SCHEMBL15084444 0.85 LMNA (0.56) CYP3A4TSHRLMNAMAPT
SCHEMBL28460059 0.76 PKM (0.51) TSHRIDO1AGXTTRPV6CA1
SCHEMBL9618007 0.76 PKM (0.51) TSHRIDO1AGXTTRPV6CA1
SCHEMBL9234580 0.76 PKM (0.51) TSHRIDO1AGXTTRPV6CA1
SCHEMBL24114701 0.74 TDP1 (0.51) LMNAIDO1AGXT
SCHEMBL18236136 0.71 LMNA (0.44) CYP3A4TSHRLMNAGRM2ALDH1A1
SCHEMBL13408694 0.71 SMN1; SMN2 (0.51) TSHRLMNAALDH1A1MEN1KMT2A
SCHEMBL16770103 0.71 SMN1; SMN2 (0.51) TSHRLMNAALDH1A1MEN1KMT2A
SCHEMBL16686216 0.70 IDO1 (0.43) CYP3A4TSHRIDO1AGXTTRPV6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018049534-A1 NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2' POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT LCB PHARMA INC. (CA) 2018-03-22 WO disclosed